Gottlieb’s first 100 days . . .

Gottlieb Issues Fewer Guidances And Delays Some Key Rules, But Hasn't Chopped Any Yet

August 22, 2017
FDA has issued fewer guidance documents and delayed some key rules during Scott Gottlieb's first 100 days as agency chief, but has yet to chop any major existing regulations despite the strong deregulatory press by a Trump White House intent on scaling back federal regulations. Industry stakeholders and some congressional Republicans are satisfied with Gottlieb's approach to date, but consumer advocates are still wary of the slowed regulatory pace. The advocates hold up FDA's delay of a highly watched tobacco...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.